Inventor · disambiguated record
Xu Wang
Also filed as: WANG XU · WANG XU-SHAN
5 granted patents·11 pending applications·84 citations·filing 1997–2023
77Inventor score
Files withREGENXBIO INC6CHIRON CORP3ONCOLMMUNE INC2UNIV HONG KONG SCIENCE & TECH2ADVANCED RES & TECH INST1
Top patents by PatentIndex Score
16 records- 0186US6521225B1AAV vectorsCHIRON CORP·Filed 1997·Granted Feb 18, 2003·57 cites·6 claims
- 0275US11098072B2Alkenyl and beta-substituted phosphonates as antimicrobial agentsUNIV GEORGE WASHINGTON·Filed 2018·Granted Aug 24, 2021·2 cites·22 claims
- 0365US2025249127A1Gene therapy for treating an ocular diseaseREGENXBIO INC·Filed 2023·Application pending·0 cites
- 0465US2024141356A1Driving Axon Regeneration by Activating STAT1 Signaling and cGAS-STING PathwayUNIV HONG KONG SCIENCE & TECH·Filed 2023·Application pending·0 cites
- 0562US12016933B2Method for stimulating axonal regenerationUNIV HONG KONG SCIENCE & TECH·Filed 2020·Granted Jun 25, 2024·0 cites·5 claims
- 0662US7052692B1Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expressionADVANCED RES & TECH INST·Filed 1998·Granted May 30, 2006·25 cites·35 claims
- 0760US2025288697A1Vectorized anti-tnf-alpha inhibitors for ocular indicationsREGENXBIO INC·Filed 2023·Application pending·0 cites
- 0856US2024384292A1Vectorized tnf-alpha antagonists for ocular indicationsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 0954US2003166284A1Methods and compositions for liver specific delivery of therapeutic molecules using recombinant AAV vectorsCHIRON CORP·Filed 2002·Application pending·0 cites
- 1053US12122799B2Antibiotics for veterinary staphylococcal infectionsTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2019·Granted Oct 22, 2024·0 cites·5 claims
- 1153US2023381341A1Adeno-associated viruses for ocular delivery of gene therapyREGENXBIO INC·Filed 2021·Application pending·0 cites
- 1252US2001051611A1Methods and compositions for liver specific delivery of therapeutic molecules using recombinant AAV vectorsCHIRON CORP·Filed 2001·Application pending·0 cites
- 1350US2023391864A1Vectorized anti-tnf-alpha antibodies for ocular indicationsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 1446US2022000974A1Targeting CD24-Siglec Interactions for Treating Subjects with Prediabetes or DiabetesONCOLMMUNE INC·Filed 2020·Application pending·0 cites
- 1545US2022000973A1Targeting CD24-Siglec Interactions for the Treatment and Prevention of Nonalcoholic SteatohepatitisONCOLMMUNE INC·Filed 2020·Application pending·0 cites
- 1643US2022195462A1Fully-human post-translationally modified antibody therapeuticsREGENXBIO INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xu Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →